期刊文献+

胃内滞留漂浮给药系统中使用草药根除幽门螺旋杆菌的研究进展(英文) 被引量:5

Gastroretentive floating drug delivery systems with potential herbal drugs for Helicobacter pylori eradication:a review
下载PDF
导出
摘要 Helicoacter pylori are very common patho-genic bacteria colonizing about half of all popula-tions and associated with the development of seti-ous gastroduodenal diseases like gastric lvm-phoma,peptic ulcers and acute chronic gastritis.Current drug regimes are not wholly effective. Helicobacter pylori are very common pathogenic bacteria colonizing about half of all populations and associated with the development of serious gastroduodenal diseases like gastric lymphoma, peptic ulcers and acute chronic gastritis. Current drug regimes are not wholly effective. Other problems related with the current drug regimes are lack of patient compliance, side effects and bacterial resistance. Thus, drug deliyery to the site of residence in the gastric mucosa may help in solving the problems associated with the current drug therapy. Gastric retentive delivery systems potentially allow increased penetration and thus increased drug concentration at thesite of action.
出处 《中西医结合学报》 CAS 2009年第10期976-982,共7页 Journal of Chinese Integrative Medicine
关键词 幽门螺旋杆菌 胃滞留剂 漂浮剂型 草药 黑柯子 黄连素 Helicobacter pylori gastroretentive dosage forms floating dosage forms herbal drugs black myrobalan berberine
  • 相关文献

参考文献47

  • 1Andreiea V, Sandica-Andreica B, Draghici A, Chiorean E, Georoceanu A, Rusu M. The prevalence of anti- Helicobacter pylori antibodies in the patients with ischemic heart disease. Rom J Intern Med. 2004; 42(1): 183-189. 被引量:1
  • 2Morgner A, Bayerdorffer E, Neubauer A, Stolte M. Malignant tumors of the stomach. Gastric mucosaassociated lymphoid tissue lymphoma and Helicobacter pylori. Gastroenterol Clin North Am. 2000,29 (3):593-607. 被引量:1
  • 3Kawahara Y, Mizuno M, Yoshino T, Yokota K, Oguma K, Okeda H, Fujiki S, Shiratori Y. HLA- DQA1 * 0103-DQB1 * 0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2005, 3 (9) : 865-868. 被引量:1
  • 4Marshall B. Helicobacter pylori: 20 years on. Clin Med. 2002, 2(2): 147-152. 被引量:1
  • 5Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mueosal injury. J Gastroenterol Hepatol. 2000; 15 Suppl: D46-D54. 被引量:1
  • 6Lehmann FS, Terracciano L, Carena I, Baeriswyl C, Drewe J, Tornillo L, De Libero G, Beglinger C. Insitu correlation of cytokine secretion and apoptosis in Helicobacter pylori-assoeiated gastritis. Am J Physiol Gastrointest Liver Physiol. 2002,283(2): G481-G488. 被引量:1
  • 7Papini E, Zoratti M, Cover TL. In search of the Helicobacter pylori VacA mechanism of action. Toxicon. 2001; 39(11): 1757-1767. 被引量:1
  • 8Blanchard TG, Drakes ML, Czinn SJ. Helicobacter infection: pathogenesis. Curr Opin Gastroenterol. 2004; 20(1) : 10-15. 被引量:1
  • 9Atherton JC. The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Annu Rev Pathol. 2006, 1: 63-96. 被引量:1
  • 10Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther.2004; 19(11): 1181-1188. 被引量:1

共引文献130

同被引文献90

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部